Crystallographic fragment screening against SARS-CoV-2 nonstructural protein 1 using the F2X-Entry Screen and a newly developed fragment library
Acta Crystallographica Section D Structural Biology · 2025
DOI: 10.1107/s2059798325008563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Crystallographica Section D Structural Biology, 2025. Verfasst von Frank Lennartz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Macromolecular Crystallography, Helmholtz-Zentrum Berlin für Materialien und Energie, Albert-Einstein-Strasse 15, 12489 Berlin, Germany. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, SARS-CoV-2, Antiviral Agents, Small Molecule Libraries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Helmholtz-Gemeinschaft.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to threaten global health. This underpins the need for novel therapeutics against this virus. Nonstructural protein 1 (Nsp1) of SARS-CoV-2 is a multifunctional protein with an essential role in viral replication. As such, it presents itself as an attractive target for drug discovery. Here, we describe two crystallographic fragment-screening campaigns against Nsp1, one using the established F2X-Entry Screen and one using a new, chemically and structurally diverse fragment library, which we call the KIT library. Together, 21 hits could be identified from 192 screened fragments, which constitutes the highest hit rate reported for Nsp1 to date. Many hits bind to a key functional region and interact with residues involved in cellular mRNA cleavage, ribosome binding and viral RNA recognition. Furthermore, most of the identified fragments share a common binding mode, providing promising starting points for further optimization into drug-like compounds that can disrupt the role of Nsp1 in viral replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macromolecular Crystallography, Helmholtz-Zentrum Berlin für Materialien und Energie, Albert-Einstein-Strasse 15, 12489 Berlin, Germany.
- Institute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Kaiserstrasse 12, 76131 Karlsruhe, Germany.
ORCID-Profile: Jan Wollenhaupt, Melanie Oelker, Uwe Mueller, Nicole Jung, Manfred S Weiss
Förderung
- Deutsche Forschungsgemeinschaft
- Helmholtz-Gemeinschaft
Zitieren
APA
Lennartz, F., Wollenhaupt, J., Oelker, M., Fröling, P., Mueller, U., Deckers, A., Grathwol, C., Bräse, S., Jung, N., & Weiss, M. S. (2025). Crystallographic fragment screening against SARS-CoV-2 nonstructural protein 1 using the F2X-Entry Screen and a newly developed fragment library. Acta Crystallographica Section D Structural Biology. https://doi.org/10.1107/s2059798325008563
Vancouver
Lennartz F, Wollenhaupt J, Oelker M, Fröling P, Mueller U, Deckers A, et al. Crystallographic fragment screening against SARS-CoV-2 nonstructural protein 1 using the F2X-Entry Screen and a newly developed fragment library. Acta Crystallographica Section D Structural Biology. 2025. doi:10.1107/s2059798325008563
BibTeX
@article{Lennartz2025,
author = {Lennartz, Frank and Wollenhaupt, Jan and Oelker, Melanie and Fröling, Paula and Mueller, Uwe and Deckers, Anke and Grathwol, Christoph and Bräse, Stefan and Jung, Nicole and Weiss, Manfred S},
title = {Crystallographic fragment screening against SARS-CoV-2 nonstructural protein 1 using the F2X-Entry Screen and a newly developed fragment library},
journal = {Acta Crystallographica Section D Structural Biology},
year = {2025},
doi = {10.1107/s2059798325008563}
}
EUVIMED